Allspring Global Investments
GSK icon

Allspring Global Investments’s GSK GSK Stock Holding History

Allspring Global Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.27M Buy
22,481
+5,876
+35% +$318K ﹤0.01% 1132
2025
Q4 		$817K Buy
16,605
+5,442
+49% +$254K ﹤0.01% 1219
2025
Q3 		$496K Sell
11,163
-1,741
-13% -$68K ﹤0.01% 1352
2025
Q2 		$500K Buy
12,904
+491
+4% +$18.8K ﹤0.01% 1348
2025
Q1 		$464K Buy
12,413
+1,248
+11% +$45.7K ﹤0.01% 1472
2024
Q4 		$374K Sell
11,165
-599
-5% -$21.6K ﹤0.01% 1526
2024
Q3 		$481K Buy
11,764
+3,405
+41% +$139K ﹤0.01% 1485
2024
Q2 		$322K Sell
8,359
-5,187
-38% -$218K ﹤0.01% 1610
2024
Q1 		$581K Buy
13,546
+4,126
+44% +$170K ﹤0.01% 1493
2023
Q4 		$349K Hold
9,420
– – ﹤0.01% 1576
2023
Q3 		$341K Hold
9,420
– – ﹤0.01% 1610
2023
Q2 		$336K Buy
9,420
+3,100
+49% +$111K ﹤0.01% 1659
2023
Q1 		$225K Hold
6,320
– – ﹤0.01% 1787
2022
Q4 		$222K Hold
6,320
– – ﹤0.01% 1802
2022
Q3 		$185K Hold
6,320
– – ﹤0.01% 1846
2022
Q2 		$343K Hold
6,320
– – ﹤0.01% 1671
2022
Q1 		$344K Sell
6,320
-2,320
-27% -$126K ﹤0.01% 2386
2021
Q4 		$476K Buy
+8,640
New +$449K ﹤0.01% 2316

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Allspring Global Investments's GSK Position: Q1 2026 in Review

Allspring Global Investments increased its GSK (GSK) stake by 35% in Q1 2026, buying an estimated $318K and bringing the position to 22,481 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1132.

Allspring Global Investments first reported a position in GSK in Q4 2021 and has held it in 18 quarters since. 1,034 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Allspring Global Investments held 22,481 shares of GSK worth $1.27M as of Q1 2026.
  • Allspring Global Investments bought 5,876 GSK shares in Q1 2026, an estimated $318K.
  • GSK made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1132 holding.
  • Allspring Global Investments first reported a position in GSK in Q4 2021 and has held it in 18 quarters since.
  • 1,034 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.